Company intelligence / Profile preview

Neuro-Engineering

Santa Rosa, California, United States

Ownership: Private
Development stage: Other

Overview

Neuro-Engineering was a medical technology company focused on the development of advanced neurostimulation systems for the treatment of chronic pain and other neurological conditions. The company specialized in creating implantable devices designed to modulate neural activity through electrical stimulation, providing an alternative to pharmacological interventions. Its core technology aimed to improve patient outcomes by offering more precise and adjustable stimulation parameters. Neuro-Engineering was eventually acquired by Medtronic, a global leader in medical technology, which integrated the company's innovations into its extensive neuromodulation portfolio.

Therapeutic areas: Neurology
Modalities: Device
Industry: Implantable Medical Devices

Beyond the preview

Go deeper on Neuro-Engineering.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neuro-Engineering.

Explore the full profile